Janet S Sunness
Overview
Explore the profile of Janet S Sunness including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
61
Citations
1210
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Kong X, Ibrahim-Ahmed M, Bittencourt M, Strauss R, Birch D, Cideciyan A, et al.
Am J Ophthalmol
. 2021 Oct;
236:32-44.
PMID: 34695402
Purpose: To estimate and compare cross-sectional scotopic versus mesopic macular sensitivity losses measured by microperimetry, and to report and compare the longitudinal rates of scotopic and mesopic macular sensitivity losses...
12.
Schonbach E, Strauss R, Cattaneo M, Fujinami K, Birch D, Cideciyan A, et al.
Am J Ophthalmol
. 2021 Jul;
233:78-89.
PMID: 34298008
Purpose: Stargardt disease type 1 (STGD1) is the most common macular dystrophy. The assessment of fixation describes an important dimension of visual function, but data on its progression over time...
13.
Schonbach E, Janeschitz-Kriegl L, Strauss R, Cattaneo M, Fujinami K, Birch D, et al.
Am J Ophthalmol
. 2021 May;
230:123-133.
PMID: 33951446
Purpose: To report the yearly rate of change in macular function in patients with Stargardt disease type 1 (STGD1) over 24 months and to establish a new volumetric visual function...
14.
Kaleem M, Rajjoub R, Schiefer C, Wall J, Applegate C, Tian J, et al.
Ophthalmol Glaucoma
. 2021 Mar;
4(6):638-645.
PMID: 33722789
Purpose: In this study, we describe common demographic and clinical characteristics of the glaucoma patient population attending vision rehabilitation. Design: Cross-sectional study. Participants: Patients attending a hospital-based vision rehabilitation center...
15.
Schonbach E, Strauss R, Munoz B, Wolfson Y, Ibrahim M, Birch D, et al.
JAMA Ophthalmol
. 2020 May;
138(7):772-779.
PMID: 32463436
Importance: Functional end points for clinical trials investigating the efficacy of emerging treatments for Stargardt disease type 1 (STGD1) are needed. Objective: To assess the yearly rate of change of...
16.
Schonbach E, Strauss R, Ibrahim M, Janes J, Cideciyan A, Birch D, et al.
Am J Ophthalmol
. 2020 May;
217:305-316.
PMID: 32422174
Purpose: Sensitive, reproducible visual function biomarkers are necessary to evaluate the efficacy of emerging treatments for Stargardt disease type 1 in clinical trials. We previously demonstrated that fixation stability may...
17.
Sunness J, Ifrah A, Wolf R, Applegate C, Sparrow J
Invest Ophthalmol Vis Sci
. 2020 Apr;
61(4):36.
PMID: 32334431
Purpose: To examine the extent of visual function abnormality outside the dark lesion on short-wavelength fundus autofluorescence (SW-AF), and its correlation with background SW-AF features and optical coherence tomography (OCT)...
18.
Schonbach E, Strauss R, Ibrahim M, Janes J, Birch D, Cideciyan A, et al.
Am J Ophthalmol
. 2020 Mar;
216:219-225.
PMID: 32222369
Purpose: Mean sensitivity (MS) derived from a standard test grid using microperimetry is a sensitive outcome measure in clinical trials investigating new treatments for degenerative retinal diseases. This study hypothesizes...
19.
Strauss R, Kong X, Ho A, Jha A, West S, Ip M, et al.
JAMA Ophthalmol
. 2019 Aug;
137(10):1134-1145.
PMID: 31369039
Importance: Sensitive outcome measures for disease progression are needed for treatment trials of Stargardt disease. Objective: To estimate the progression rate of atrophic lesions in the prospective Natural History of...
20.
Schonbach E, Ibrahim M, Strauss R, Birch D, Cideciyan A, Hahn G, et al.
Ophthalmol Retina
. 2019 May;
1(1):68-76.
PMID: 31047397
Purpose: To determine fixation location and fixation stability in Stargardt disease (STGD1) and their association with best-corrected visual acuity (BCVA). Design: Cross-sectional analysis within the multicenter, prospective ProgStar study. Participants:...